Literature DB >> 17099918

An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform.

Vaishali Bagalkot1, Omid C Farokhzad, Robert Langer, Sangyong Jon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17099918     DOI： 10.1002/anie.200602251

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  149 in total

Review 1.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

Review 2.  Cell-specific aptamer-mediated targeted drug delivery.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Oligonucleotides       Date:  2010-12-23

Review 3.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 4.  Tumor-targeted drug delivery with aptamers.

Authors:  Y Zhang; H Hong; W Cai
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

5.  A unique aptamer-drug conjugate for targeted therapy of multiple myeloma.

Authors:  J Wen; W Tao; S Hao; S P Iyer; Y Zu
Journal:  Leukemia       Date:  2015-08-05       Impact factor: 11.528

Review 6.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

7.  Preparation and biomedical applications of programmable and multifunctional DNA nanoflowers.

Authors:  Yifan Lv; Rong Hu; Guizhi Zhu; Xiaobing Zhang; Lei Mei; Qiaoling Liu; Liping Qiu; Cuichen Wu; Weihong Tan
Journal:  Nat Protoc       Date:  2015-09-10       Impact factor: 13.491

8.  Intra-tumoral drug concentration mapping within solid tumor micro-milieu using in-vitro model and doxorubicin as a model drug.

Authors:  Ahmed M Al-Abd; Alaa Khedr; Salah G Atteiah; Fahad A Al-Abbasi
Journal:  Saudi Pharm J       Date:  2020-05-11       Impact factor: 4.330

Review 9.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

10.  Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells.

Authors:  Partha Ray; Marcus A Cheek; Mariam L Sharaf; Na Li; Andrew D Ellington; Bruce A Sullenger; Barbara Ramsay Shaw; Rebekah R White
Journal:  Nucleic Acid Ther       Date:  2012-10       Impact factor: 5.486
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.